Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies

Author(s): Anderson JW, Kendall CW, Jenkins DJ

Abstract

Obesity is a major risk factor for development of diabetes, and excessive energy intake is a major contributor to poor glycemic control in Type 2 diabetes. The impact of obesity on risk for diabetes as well as coronary heart disease (CHD) risk factors and the benefits of weight loss in decreasing risk for developing diabetes and improving glycemia and CHD risks were reviewed. A systematic review of the medical literature to assess the impact of obesity and weight gain on risk for diabetes and CHD was done. We performed a meta-analysis of the effects of weight loss for obese diabetic individuals. Controlled clinical trials assessing lifestyle changes on risk for developing diabetes and weight loss effects on glycemia and CHD risk factors were reviewed. Obesity and weight gain can increase risk for diabetes by greater than ninetyfold and CHD by about sixfold. Very-low-energy diets (VLED) decrease fasting plasma glucose values by approximately 50% within two weeks and these changes are sustained with continued energy restriction. Twelve weeks of energy-restricted diets were associated with these significant decreases: body weight, 9.6%; fasting plasma glucose, 25.7%; serum cholesterol, 9.2%; serum triglycerides, 26.7%; systolic blood pressure, 8.1%; and diastolic blood pressure, 8.6%. Larger weight losses were associated with larger reductions in these values. The reviewed data suggest that US health care providers should endorse the American Heart Association's and European diabetes associations' recommendations that diabetic persons achieve and maintain a BMI of <or=25 kg/m(2). Weight management may be the most important therapeutic task for most obese Type 2 diabetic individuals.

Similar Articles

Global guidelines for type 2 diabetes

Author(s): IDF Clinical Guidelines Task Force

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

Author(s): Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al.

Computer modeling of diabetes and its complications

Author(s): The Mount Hood 4 Modeling Group

A clinical prediction rule for delirium after elective noncardiac surgery

Author(s): Marcantonio ER, Goldman L, Mangione CM, Ludwig LE, Muraca B, et al.

Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study

Author(s): van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, et al.

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)

Author(s): Stevens RJ, Kothari V, Adler AI, Stratton IM; United Kingdom Prospective Diabetes Study (UKPDS) Group

Risk factors for diabetic peripheral sensory neuropathy

Author(s): Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, et al.

Risk factors for renal dysfunction in type 2 diabetes: U

Author(s): Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR

Preserving renal function in adults with hypertension and diabetes: a consensus approach

Author(s): Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, et al.

Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes

Author(s): Park JY, Kim HK, Chung YE, Kim SW, Hong SK, et al.

Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension

Author(s): Tuomilehto J, Rastenyte D, Birkenhäger WH, Thijs L, Antikainen R, et al.

The Metabolic Syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects

Author(s): Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, et al.